BBLG · Bone Biologics Corp · Executive Compensation
$0.49
+0.01 (+2.06%)
At close · Oct 5
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt about the Company's ability to continue as a going concern within one year after the date that the financial statements are issued.”View the 10-Q filed Aug 14, 2026
Market Cap
$1.37M
Shares
2.76M
Volume · Oct 5
26.26K
Avg daily vol (3M)
379.16K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Jeffrey Frelick | Chief Executive Officer and President | $426,269 |
| Deina H. Walsh | Chief Financial Officer | $263,136 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Jeffrey Frelick | Chief Executive Officer and President | $384,897 |
| Deina H. Walsh | Chief Financial Officer | $242,448 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Jeffrey Frelick | Chief Executive Officer and President | $376,600 |
| Deina H. Walsh | Chief Financial Officer | $238,300 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Jeffrey Frelick | Chief Executive Officer and President | $414,715 |
| Deina H. Walsh | Chief Financial Officer | $250,458 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Jeffrey Frelick | Chief Executive Officer and President | $290,000 |
| Deina H. Walsh | Chief Financial Officer | $21,100 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Phillip Meikle | Board of Directors | Appointed | 2024-10-21 |
| Don Hankey | director | Resigned | 2024-10-04 |
| Erick Lucera | Board of Directors | Resigned | 2024-01-11 |
| Robert E. Gagnon | Board of Directors | Appointed | 2024-01-11 |
| Erick Lucera | director | Resigned | 2024-01-02 |
| Stephen LaNeve | director | Resigned | 2022-12-21 |